KLK3 and Familial prostate cancer: Details of the data collection, which involved clinicians auditing coded and free-text electronic healthcare records data, has been outlined in previous publications.9,10 The current study aimed to analyse the 2018 NCDA data to understand factors affecting asymptomatic PSA testing in English primary care before diagnosis for patients with prostate cancer.